The global EPA and DHA market is estimated to be valued at US$ 1,626.10 Mn in 2022 and is expected to exhibit a CAGR of 6.76% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are omega-3 fatty acids commonly found in fish oil and certain algae. These fatty acids are essential for the proper functioning of the ... Read more
EPA and DHA are essential fatty acids that support cardiovascular and brain health. They are key components of fish oil and algal oil that are used in various functional foods and dietary supplements to enhance nutritional profiles and supply health benefits associated with omega-3 fatty acids. EPA and DHA omega-3 ingredients are used in various products ranging from infant formulas and supplements to functional beverages and clinical nutrition.
Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are considered critical for human health. The omega-3 fatty acids EPA and DHA are mainly derived from fish and fish oil. They are highly recommended for health conditions such as cardiovascular diseases, high blood pressure, high triglycerides levels, cognitive decline, other neurological disorders, as well as dry eye disease. In recent times demand for EPA and DHA ingredients has increased notably for use in infant formulas, ... Read more
